Hersh D - Search Results

1

Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics.

Korthuis PT, Tozzi MJ, Nandi V, Fiellin DA, Weiss L, Egan JE, Botsko M, Acosta A, Gourevitch MN, Hersh D, Hsu J, Boverman J, Altice FL; BHIVES Collaborative. Korthuis PT, et al. Among authors: hersh d. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S39-45. doi: 10.1097/QAI.0b013e318209754c. J Acquir Immune Defic Syndr. 2011. PMID: 21317593 Free PMC article.

2

The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.

Sullivan LE, Botsko M, Cunningham CO, O'Connor PG, Hersh D, Mitty J, Lum PJ, Schottenfeld RS, Fiellin DA; BHIVES Collaborative. Sullivan LE, et al. Among authors: hersh d. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S54-61. doi: 10.1097/QAI.0b013e3182097576. J Acquir Immune Defic Syndr. 2011. PMID: 21317595 Free PMC article.

3

Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings.

Lum PJ, Little S, Botsko M, Hersh D, Thawley RE, Egan JE, Mitty J, Boverman J, Fiellin DA; BHIVES Collaborative. Lum PJ, et al. Among authors: hersh d. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S91-7. doi: 10.1097/QAI.0b013e31820a9a82. J Acquir Immune Defic Syndr. 2011. PMID: 21317601

4

Cigarette Smoking Cessation Intervention for Buprenorphine Treatment Patients.

Hall SM, Humfleet GL, Gasper JJ, Delucchi KL, Hersh DF, Guydish JR. Hall SM, et al. Nicotine Tob Res. 2018 Apr 2;20(5):628-635. doi: 10.1093/ntr/ntx113. Nicotine Tob Res. 2018. PMID: 28549161 Free PMC article. Clinical Trial.

5

Integrating buprenorphine treatment into a public healthcare system: the San Francisco Department of Public Health's office-based Buprenorphine Pilot Program.

Hersh D, Little SL, Gleghorn A. Hersh D, et al. J Psychoactive Drugs. 2011 Apr-Jun;43(2):136-45. doi: 10.1080/02791072.2011.587704. J Psychoactive Drugs. 2011. PMID: 21858959

6

Naltrexone treatment of comorbid alcohol and cocaine use disorders.

Hersh D, Van Kirk JR, Kranzler HR. Hersh D, et al. Psychopharmacology (Berl). 1998 Sep;139(1-2):44-52. doi: 10.1007/s002130050688. Psychopharmacology (Berl). 1998. PMID: 9768541 Clinical Trial.

7

Methamphetamine quantitative urine concentrations during a controlled trial of fluoxetine treatment. Preliminary analysis.

Batki SL, Moon J, Delucchi K, Bradley M, Hersh D, Smolar S, Mengis M, Lefkowitz E, Sexe D, Morello L, Everhart T, Jones RT, Jacob P 3rd. Batki SL, et al. Among authors: hersh d. Ann N Y Acad Sci. 2000;909:260-3. doi: 10.1111/j.1749-6632.2000.tb06688.x. Ann N Y Acad Sci. 2000. PMID: 10911936 Clinical Trial. No abstract available.

8

Unintended consequences of a quality improvement program designed to improve treatment of alcohol withdrawal in hospitalized patients.

Pletcher MJ, Fernandez A, May TA, Westphal JR, Gamez CA, Hersh DF, Gonzales R. Pletcher MJ, et al. Jt Comm J Qual Patient Saf. 2005 Mar;31(3):148-57. doi: 10.1016/s1553-7250(05)31020-8. Jt Comm J Qual Patient Saf. 2005. PMID: 15828598

9

Carbamazepine and cocaine-cue reactivity.

Hersh D, Bauer LO, Kranzler HR. Hersh D, et al. Drug Alcohol Depend. 1995 Oct;39(3):213-21. doi: 10.1016/0376-8716(95)01165-3. Drug Alcohol Depend. 1995. PMID: 8556970 Clinical Trial.

10

Effects of naltrexone on cue-elicited craving for alcohol and cocaine.

Modesto-Lowe V, Burleson JA, Hersh D, Bauer LO, Kranzler HR. Modesto-Lowe V, et al. Among authors: hersh d. Drug Alcohol Depend. 1997 Dec;49(1):9-16. doi: 10.1016/s0376-8716(97)00134-8. Drug Alcohol Depend. 1997. PMID: 9476694 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page